Danaher Target of Unusually High Options Trading (DHR)

Danaher Co. (NYSE:DHR) was the target of unusually large options trading on Monday. Investors purchased 2,617 put options on the company. This is an increase of 1,256% compared to the typical daily volume of 193 put options.

Several brokerages recently weighed in on DHR. Robert W. Baird reissued a “buy” rating on shares of Danaher in a report on Friday. Goldman Sachs Group reissued a “neutral” rating and issued a $83.00 price objective on shares of Danaher in a report on Tuesday, September 26th. Evercore ISI assumed coverage on Danaher in a report on Wednesday, January 3rd. They issued an “outperform” rating for the company. Royal Bank of Canada restated a “hold” rating and issued a $96.00 target price on shares of Danaher in a research note on Thursday, January 4th. Finally, Cowen restated a “buy” rating and issued a $90.00 target price on shares of Danaher in a research note on Wednesday, October 4th. One analyst has rated the stock with a sell rating, six have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $94.91.

In related news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at $25,173,715.68. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the sale, the director now directly owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 273,810 shares of company stock worth $25,218,813. Corporate insiders own 12.20% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after buying an additional 520,776 shares during the period. BlackRock Inc. boosted its position in shares of Danaher by 3.2% during the second quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after buying an additional 1,233,876 shares during the period. FMR LLC raised its holdings in Danaher by 0.9% during the second quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after purchasing an additional 183,183 shares in the last quarter. Parnassus Investments CA raised its holdings in Danaher by 0.3% during the third quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after purchasing an additional 29,381 shares in the last quarter. Finally, Flossbach Von Storch AG raised its holdings in Danaher by 17.2% during the third quarter. Flossbach Von Storch AG now owns 6,776,921 shares of the conglomerate’s stock worth $581,324,000 after purchasing an additional 994,902 shares in the last quarter. Institutional investors and hedge funds own 76.05% of the company’s stock.

Danaher (NYSE:DHR) opened at $99.39 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. Danaher has a 52 week low of $78.97 and a 52 week high of $99.66. The company has a market capitalization of $69,140.00, a P/E ratio of 29.58, a price-to-earnings-growth ratio of 2.14 and a beta of 1.03.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.87 earnings per share. equities research analysts predict that Danaher will post 3.99 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a dividend of $0.14 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.56%. Danaher’s dividend payout ratio is presently 16.67%.

TRADEMARK VIOLATION NOTICE: This article was first posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.thelincolnianonline.com/2018/01/14/stock-traders-buy-high-volume-of-put-options-on-danaher-dhr-updated-updated.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply